Facebook
Twitter
Telegram
Report an ErrorKindred Biosciences, Inc. Financial Statements 2011-2024 | KIN
Annual Financial Statements Kindred Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
196 M | 351 M | 305 M | 222 M | 128 M | 65.3 M | 119 M | 61.6 M | - | - |
Shares |
39.3 M | 38.7 M | 31 M | 25.1 M | 19.9 M | 19.8 M | 18.8 M | 3.73 M | - | - |
Net Income |
-21.8 M | -61.4 M | -49.7 M | -30.9 M | -22.5 M | -27.1 M | -27.1 M | -1.83 M | -120 K | - |
Revenue |
42.2 M | 4.26 M | 1.97 M | - | - | - | - | - | - | - |
EBITDA |
-11 M | -60 M | -50.5 M | -31.2 M | -22 M | -27.1 M | -27.2 M | -1.83 M | -120 K | - |
Operating Expenses |
53.3 M | 66.2 M | 52.9 M | 31.7 M | 22.2 M | 27.3 M | 27.2 M | - | - | - |
General and Administrative Expenses |
22 M | 37.9 M | 22.1 M | 11.9 M | 6.84 M | 6.86 M | 8.54 M | 438 K | 45 K | - |
All numbers in USD currency